Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 52 results.
Malikova M., Webster P., Brahmbhatt T. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23, September 2022 Verona, Italy. Establishing Patient Safety Monitoring in the Benefit-Risk Paradigm for Off-Label and Emergency Use of Medications for COVID-19: A Pharmacovigilance Perspective. Drug Safety. Drug Safety. 2022; (45):1199–1200. View Publication
Palin K., V. Kugener V., Salas M., Malikova M., Price J., Webster P., Cole A., Ely D., Habibi S., Joshi P. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities”. Am2P: A New Accredited Academic Training Program in Pharmacovigilance and Pharmacoepidemiology Designed for US, Canadian and Caribbean Healthcare Professionals. Drug Safety. 2022; (45):1275–1276. View Publication
Malikova M. and Kaliaev A. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities”. Risk-Based Quality and Safety Management in Clinical Trials with Combination Devices in Changing Global Regulatory Environment. Drug Safety. Drug Safety. 2022; (45):1267. View Publication
Cole A, Webster P, Van Liew D, Salas M, Aimer O, Malikova MA. Safety surveillance and challenges in accelerated COVID-19 vaccine development. Ther Adv Drug Saf. 2022; 13:20420986221116452. PMID: 36072284; PMCID: PMC9444812; DOI: 10.1177/20420986221116452;
Li Y, He Y, Falzon I, Fairbourn B, Tingey S, Imrey PB, Radeva MK, Beck GJ, Gassman JJ, Roy-Chaudhury P, Berceli SA, Cheung AK, Shiu YT. Dynamic Remodeling of Human Arteriovenous Fistula Wall Obtained From Magnetic Resonance Imaging During the First 6 Months After Creation. Kidney Int Rep. 2022 Aug; 7(8):1905-1909. PMID: 35967120; PMCID: PMC9366358; DOI: 10.1016/j.ekir.2022.05.016;
Malikova M, Jara H, Slanetz PJ. Evaluation of non-palpable breast lesions by quantitative magnetic resonance imaging in correlation with histopathology and radiological findings. 2022. View Publication
Malikova MA. Biologics Development: A Regulatory Overview. Biosimilars. Barnette International Publishing Group. 2021.
Malikova M.A. Impact of COVID-19 pandemic on conduct of clinical trials: lessons learned for risk and change management. International Journal of Clinical Trials. 2021; 8(1).
Malikova MA. Practical applications of regulatory requirements for signal detection and communications in pharmacovigilance. Ther Adv Drug Saf. 2020; 11:2042098620909614. PMID: 32313617; PMCID: PMC7160767; DOI: 10.1177/2042098620909614;
Kaliaev AO, Malikova MA. Risk-Based Quality and Compliance Management in Clinical Trials with Combination Products in Changing Global Regulatory Environment. Ther Innov Regul Sci. 2020 07; 54(4):803-813. PMID: 32557305
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.